Patents by Inventor Felicity Dunlop

Felicity Dunlop has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monoclonal antibody against Interleukin-13 receptor alpha 1 (IL-13Ralpha1)
    Publication number: 20050058645
    Abstract: The present invention relates generally to antibodies that bind to the Interleukin-13 receptor ?1 chain (IL-13R?1) and antagonize IL-13 receptor-mediated signaling by IL-13 and/or IL-4. More particularly, the present invention provides humanized or human antibodies to mammalian and in particular IL-13R?1. These antibodies have uses in the treatment or prevention of IL-13- and/or IL-4-mediated diseases or conditions. The present invention further contemplates a method of modulating IL-13- and/or IL-4-mediated diseases or conditions by the administration of the subject antibodies. The present invention further provides an assay system useful for identifying antibodies or other agents which modulate IL-13 and/or IL-4 signaling through an IL-13 receptor complex. Accordingly, a method of screening for modulators of IL-13R?1/ligand interaction is also provided.
    Type: Application
    Filed: May 20, 2004
    Publication date: March 17, 2005
    Applicant: AMRAD OPERATIONS PTY. LTD.
    Inventors: Felicity Dunlop, Manuel Baca, Andrew Nash, Louis Fabri, Douglas Hilton, Nicos Nicola